Unusual clinical and pathological presentation of a neuroendocrine tumor in a patient with multiple endocrine neoplasia type 1

Endocr J. 2009;56(7):887-95. doi: 10.1507/endocrj.k09e-126. Epub 2009 Jun 30.

Abstract

Neuroendocrine tumors develop in various organs in patients with multiple endocrine neoplasia type 1 (MEN1). Among those, tumors developed in upper gastrointestinal tract, thymus and bronchus have historically been called "carcinoid tumor". Occurrence of "carcinoid tumor" in other region is very rare and molecular pathogenesis of such tumors is unknown. We have experienced a patient with MEN1 who have developed an "ectopic" retroperitoneal neuroendocrine tumor. Genetic analysis of the MEN1 gene in tumor cells revealed a somatic mutation in exon 9 as well as a germline mutation in exon 10. Allele-specific amplification followed by sequence analysis revealed these two mutations exist on the different allele, indicating both alleles are functionally inactivated. Immunohistochemical staining with an anti-menin antibody revealed that wild-type menin is not expressed in tumor cells. Expression of p27(Kip1) protein is not observed in tumor cells, either. These results confirmed the inactivation of the MEN1 gene as a genetic cause of an ectopically developed neuroendocrine tumor in a patient with MEN1.

Publication types

  • Case Reports

MeSH terms

  • Carcinoid Tumor / pathology*
  • Cyclin-Dependent Kinase Inhibitor p27 / genetics
  • Female
  • Germ-Line Mutation
  • Humans
  • Loss of Heterozygosity
  • Middle Aged
  • Multiple Endocrine Neoplasia Type 1 / genetics
  • Multiple Endocrine Neoplasia Type 1 / pathology*
  • Neuroendocrine Tumors / genetics
  • Neuroendocrine Tumors / pathology*
  • Proto-Oncogene Proteins / genetics
  • Retroperitoneal Neoplasms / pathology

Substances

  • MEN1 protein, human
  • Proto-Oncogene Proteins
  • Cyclin-Dependent Kinase Inhibitor p27